Record Revenues and Gross Margins
LAS VEGAS, NV / ACCESSWIRE / August 2, 2022 / Australis Capital Inc. (CSE:AUSA) (OTCQB:AUSAF) ("AUSA") ("AUDACIOUS" or the "Company"), announces its unaudited results for its fiscal year ended March 31, 2022. The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB"), expressed in Canadian dollars ($CAD). The Company's independent auditors are auditing these statements, and the Company anticipates filing audited statement within the next 30 days. The Company's unaudited financial statements can be accessed at https://ausa-corp.com/investor-information/financials/
Fiscal Year 2022 Financial Highlights (April 1, 2021, to March 31, 2022)
Revenues increased by over 1,200% to nearly $9.5 million, driven predominantly by a full year of ALPS revenue consolidated (51% of ALPS acquired on March 8, 2021), as well as growth in the ALPS business throughout the year, along with management fee income starting in Fiscal '22 related to the Green Therapeutics ("GT") business.
Gross margins turned positive at nearly $5.9 million, due predominantly to results at ALPS, along with the GT-related management fee income.
Operating loss increased 38% to $19.4 million due to higher personnel and administrative costs related to the ALPS business, as well as investments in new product lines and initiatives related to expansion into other states.
The Company raised $5.8 million in equity and debt financings during FY 2022.
Total Assets stood at $63.3 million at the end of FY 2022, down from $82.4 million at the end of FY 2021, due to the sale and drop in value of the marketable securities owned (totally sold as of FY 2022) and the sale of land.
Total Liabilities increased 12% to $17.7 million.
Total Equity stood at $45.6 million as at March 31, 2022.
Operational highlights & Management Commentary
During the year ended March 31, 2022, the Company made significant progress through its expansion into multiple states, as well as internationally. The Company focused on driving sales in its core business (ALPS & GT), as well as launched new brands and product lines (LOOS, Mr. Natural, and Wreck Relief).
During the year under review, AUDACIOUS successfully entered into partnerships in Thailand (Green Triangle Holdings) and New York State (First Americans LLC, Hempire Inc.). Consequently, the Company is now present in New York with two projects, both aimed at the adult use market, that are able to operationalize and start selling well in advance of the introduction of general regulations and licensing, due to exemptions granted to licensed operations on first nations land and those related to hemp licensees. Furthermore, AUDACIOUS successfully applied for licenses in New Jersey.
Consequently, the Company is well positioned to drive further growth in Fiscal 2023.
Terry Booth, CEO, commented, "We have been able to develop a number of unique assets, from our award-winning GT brands, though our unique LOOS, Mr. Natural and Wreck Relief product lines, as well as our early mover initiatives in Thailand (revenue generating) and New York State. With our recently granted provisional license in New Jersey, where we are progressing towards conversion into a full adult use license, we believe we have assembled a portfolio of assets, the value of which is well in excess of what the market currently values us at. With our recently announced credit line and further capitalization initiatives under way, we believe AUDACIOUS is positioned exceptionally well to benefit from the strong anticipated growth on the U.S. East Coast, as well as internationally."
Subsequent Events since March 31, 2022
The Company announced considerable progress at its partnership in Thailand with Golden Triangle Holdings ("GTH"). Following the successful harvest of a trial crop, GTH has now commenced cultivation at commercial scale. Furthermore, the Company announced it had secured major distribution channels in the region, including 7eleven Pharmacies, Loxley, King Power International and others. The Company's first cannabis clinic in Thailand, Herbidus, has proven to be a hit with many hundreds of visitors monthly.
In April the Company issued 17,369,317 shares in Australis for the initial investment, in a swap for 3,600,000 shares in GTH.
In July the Company issued 38,878,435 shares in Australis for the second and final tranche to GTH.
The Company announced it had received a provisional license in New Jersey for the cultivation, processing, and manufacturing of cannabis products. The Company is progressing towards meeting the requirements for conversion into a full adult use license.
AUDACIOUS announced a partnership with Hempire, recipient of an adult use cultivation license.
The Company, through its partnership with First Americans LLC of the Saint Regis Mohawk tribe, was able to secure commence preparations for operations on the territory. The Company's planned dispensary is currently being constructed (immediately opposite the casino resort with 2.4MM visitors annually), while groundwork for cultivation has commenced.
Hempire: licensee through the NYS hemp program for cultivation, manufacturing, and distribution into the adult use market in New York State. Land secured, first outdoor planting to happen shortly.
The Company also announced it is working with Bertha Lewis and The Black Institute on its social equity initiatives in New York.
The Company launched its first product in Nevada under the Mr. Naturals brand: Full Spectrum Hash RSO. The powerful medicinal oil - rich in major and minor medicinal cannabinoids including THC, CBD, and CBN - is known for its therapeutic benefits and potential to provide relief for people suffering from post-traumatic stress disorder (PTSD), chronic illness and pain.
AUDACIOUS secured a $2.5 million credit facility from Lola Ventures, an entity controlled by CEO Terry Booth. Funds will go towards general working capital purposes, as well as growth initiatives.
On July 5, 2022, the Company announced the election of Jill Swainson, former Chief Legal Officer at Aurora Cannabis, to the board, who replaced Avi Geller, who resigned for personal reasons.
Balance Sheet Summary (Unaudited):
Fiscal Year Ended
March 31, 2022
March 31, 2021
Other Current Assets
Land Held for Sale
Intangibles & Goodwill
Derivative Financial Instrument
Other Non-Current Assets
Other Current Liabilities
Loans & Leases
Shareholders Equity Attributable to Company
Total Liabilities & Equity
Fiscal Year Ended
March 31, 2022
March 31, 2021
Cost of Sales
Depreciation and amortization
Selling, general and administrative
Wages and benefits
Loss from Operations
Other Income (expense) net
Tax recovery (expense)
Other Comprehensive Income (expense)
Attributable to Company
Net Loss per Share Attributable to Company
Weighted Average Shares Outstanding
Fiscal Year Ended
March 31, 2022
March 31, 2021
Cash Provided (Used) in Operations
Cash Provided (Used) in Investment Operations
Cash Provided (Used) in Financing Activities
Foreign Exchange Effect
Decrease in Cash
AUDACIOUS is a next-generation MSO growing the cannabis industry of tomorrow from the ground up, led by industry pioneer Terry Booth and an accomplished management team with proven industry track records. With operations that range from providing industry-leading sustainable cultivation design and optimization to retail storefronts, growing flower in-house, and manufacturing award-winning brands, AUDACIOUS has products and solutions for everyone. Quickly expanding through innovative partnerships and collaborations, AUDACIOUS is forging the inclusive cannabis community of tomorrow, today. Learn more about AUDACIOUS here.
AUDACIOUS common shares trade on the CSE under the symbol "AUSA" and on the OTCQB under the symbol "AUSAF."
Terry Booth, CEO
For further information, please contact:
Neither the Canadian Securities Exchange nor its regulation services provider accepts responsibility for the adequacy or accuracy of this news release.
This press release includes forward-looking statements, which may involve, but are not limited to: statements with respect to our business objectives, prospects, and guidance in respect of various financial and industry metrics, including, goals, strategies, capabilities, market position, competitive strengths, prospects, plans, expectations, anticipations, estimates and intentions; business and economic, industry trends; customer demand for products; the regulatory environment and legal proceedings; strength of our balance sheet, creditworthiness, capital resources, anticipated financial requirements; compliance with debt covenants; and the impact of the COVID-19 pandemic on the foregoing; expectations regarding gradual market and economic recovery in the aftermath of the COVID-19 pandemic.
Forward-looking statements can generally be identified by the use of forward-looking terminology such as "may", "will", "shall", "can", "expect", "estimate", "intend", "anticipate", "plan", "foresee", "believe", "continue", "maintain" or "align", the negative of these terms, variations of them or similar terminology.
Forward-looking statements are presented for the purpose of assisting investors and others in understanding certain key elements of our current objectives, strategic priorities, expectations, outlook, and plans, and to obtain an understanding of our business and anticipated operating environment. Readers are cautioned that such information may not be appropriate for other purposes.
Forward-looking statements require management and the Board to make assumptions and are subject to and unknown risks and uncertainties, which may cause our actual results in future periods to differ materially from forecast results set forth in forward-looking statements and in this press release. While management and the Board consider these assumptions to be reasonable and appropriate based on information currently available, there is risk that they may not be accurate. The assumptions underlying the forward-looking statements made in this press release in relation to the five-year forecast include the following material assumptions: the award and fulfilment of customer contracts that the Company does not currently have in its backlog, the continuation of existing customer programs and anticipated labour costs associated with our operations for the periods covered in the forecast. Additional information, including with respect to other assumptions and risk factors underlying the forward-looking statements made in this press release, refer to the risk factors in both our MD&A for the quarter ended December 31, 2021.
Certain factors that could cause actual results to differ materially from those anticipated in the forward-looking statements include, but are not limited to, risks associated with overall global and domestic economic conditions, risks associated with our business environment (such as risks associated with the financial condition of our customers; competition; force majeure events), operational risks such as the award of new business; the execution of customer orders; cash flows and capital expenditures; productivity enhancements, operational efficiencies, cost reduction initiatives; regulatory and legal proceedings; environmental, health and safety risks; dependence on certain partners, contracts and suppliers; supply chain risks; human resources; reliance on information systems; adequacy of insurance coverage), financing risks (such as risks related to liquidity and access to capital markets; debt covenants), market risks (such as foreign currency fluctuations; changing interest rates; increases in commodity prices; and inflation rate fluctuations). For more details, see the Risks and uncertainties section in our MD&A for the quarter ended December 31, 2021.
For further information about AUDACIOUS, please visit our website.
The forward-looking statements present certain non-IFRS financial measures to assist readers in understanding the Company's forecasted performance. Non-IFRS financial measures are measures that either exclude or include amounts that are not excluded or included in the most directly comparable measures calculated and presented in accordance with Generally Accepted Accounting Principles ("GAAP"). Reference is made to EBITDA (defined as net income before interest, income taxes, depreciation, and amortization), which the Company considers to be an indicative measure of operating performance and a metric to evaluate profitability. As there is no standardized method of calculating this measure, the Corporation's EBITDA may not be directly comparable with similarly titled measures used by other companies. In addition, reference is made to revenue in the long-term forecast, which assumes recognition of all revenue at the point in time of shipment, excluding the recognition of revenue overtime. Similarly, this is a non-IFRS financial measure the company considers to be indicative of operating performance, and is not directly comparable with similarly titled measures used by other companies.
The foregoing list of factors that may affect future results and performance is not exhaustive and undue reliance should not be placed on forward-looking statements. The forward-looking statements set forth herein reflect management's expectations as at the date of this press release and are subject to change after such date. Unless otherwise required by applicable securities laws, we expressly disclaim any intention, and assume no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
SOURCE: Australis Capital, Inc.
View source version on accesswire.com: